BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37727960)

  • 1. An overview of imidazole and its analogues as potent anticancer agents.
    Abdullah S; Ganguly S
    Future Med Chem; 2023 Sep; 15(17):1621-1646. PubMed ID: 37727960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive review in current developments of imidazole-based medicinal chemistry.
    Zhang L; Peng XM; Damu GL; Geng RX; Zhou CH
    Med Res Rev; 2014 Mar; 34(2):340-437. PubMed ID: 23740514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Significance of Imidazole-based Analogues in New Drug Development.
    Chopra PN; Sahu JK
    Curr Drug Discov Technol; 2020; 17(5):574-584. PubMed ID: 30894111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazoles as Potential Anticancer Agents: An Update on Recent Studies.
    Sharma P; LaRosa C; Antwi J; Govindarajan R; Werbovetz KA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazoles as potential anticancer agents.
    Ali I; Lone MN; Aboul-Enein HY
    Medchemcomm; 2017 Sep; 8(9):1742-1773. PubMed ID: 30108886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazole as a Promising Medicinal Scaffold: Current Status and Future Direction.
    Alghamdi SS; Suliman RS; Almutairi K; Kahtani K; Aljatli D
    Drug Des Devel Ther; 2021; 15():3289-3312. PubMed ID: 34354342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.
    Chen J; Wang Z; Li CM; Lu Y; Vaddady PK; Meibohm B; Dalton JT; Miller DD; Li W
    J Med Chem; 2010 Oct; 53(20):7414-27. PubMed ID: 20919720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
    Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R
    Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics.
    Al-Hamashi AA; Koranne R; Dlamini S; Alqahtani A; Karaj E; Rashid MS; Knoff JR; Dunworth M; Pflum MKH; Casero RA; Perera L; Taylor WR; Tillekeratne LMV
    Bioorg Chem; 2021 Nov; 116():105297. PubMed ID: 34509798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents.
    Li L; Quan D; Chen J; Ding J; Zhao J; Lv L; Chen J
    Eur J Med Chem; 2019 Dec; 184():111732. PubMed ID: 31610372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Future Prospective of a Versatile Moiety: Imidazole.
    Rani N; Kumar P; Singh R; de Sousa DP; Sharma P
    Curr Drug Targets; 2020; 21(11):1130-1155. PubMed ID: 32472996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures as Potent Microtubule Inhibitors for Anti-Cancer Therapy.
    Ding Z; Li F; Xie L; Gu M; Li C; Liu C; Peng C; Li W
    Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring and synthetic imidazoles: their chemistry and their biological activities.
    De Luca L
    Curr Med Chem; 2006; 13(1):1-23. PubMed ID: 16457636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes.
    Li SR; Tan YM; Zhang L; Zhou CH
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Target Interactions of Quinoline Derivatives as Anticancer Agents: A Review.
    Pradhan V; Salahuddin ; Kumar R; Mazumder A; Abdullah MM; Shahar Yar M; Ahsan MJ; Ullah Z
    Chem Biol Drug Des; 2022 Dec; ():. PubMed ID: 36533867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies.
    Kulkarni S; Kaur K; Jaitak V
    Anticancer Agents Med Chem; 2022; 22(10):1859-1882. PubMed ID: 34525925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazole: An Emerging Scaffold Showing its Therapeutic Voyage to Develop Valuable Molecular Entities.
    Chopra B; Dhingra AK; Prasad DN
    Curr Drug Res Rev; 2020; 12(2):103-117. PubMed ID: 31782364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry.
    Tolomeu HV; Fraga CAM
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery.
    Das R; Mehta DK; Dhanawat M
    Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.